Bayer earnings top estimates on crop science, soybean gains

Sonja Wind / Bloomberg05-12

Bayer AG posted better-than-expected profit in the first quarter, underpinned by a robust performance in its crop science unit, including a boost from soybean seeds and traits. Shares gained.(May 12):...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635244369?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 06:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635244369","market":"nz","top_or_hot":-1,"title":"Bayer earnings top estimates on crop science, soybean gains","media":"Sonja Wind / Bloomberg","content":"<div>\n<p>Bayer AG posted better-than-expected profit in the first quarter, underpinned by a robust performance in its crop science unit, including a boost from soybean seeds and traits. Shares gained.(May 12):...</p>\n\n<a href=\"https://www.theedgesingapore.com/news/agriculture/bayer-earnings-top-estimates-crop-science-soybean-gains?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS\">Source Link</a>\n\n</div>\n","source":"edge_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bayer earnings top estimates on crop science, soybean gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBayer earnings top estimates on crop science, soybean gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-12 06:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.theedgesingapore.com/news/agriculture/bayer-earnings-top-estimates-crop-science-soybean-gains?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS><strong>Sonja Wind / Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bayer AG posted better-than-expected profit in the first quarter, underpinned by a robust performance in its crop science unit, including a boost from soybean seeds and traits. Shares gained.(May 12):...</p>\n\n<a href=\"https://www.theedgesingapore.com/news/agriculture/bayer-earnings-top-estimates-crop-science-soybean-gains?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SOYB","symbol_name":"Teucrium Soybean Fund","start_time":0,"source_url":"https://www.theedgesingapore.com/news/agriculture/bayer-earnings-top-estimates-crop-science-soybean-gains?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","article_id":"2635244369","we_media_id":null,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/agriculture/bayer-earnings-top-estimates-crop-science-soybean-gains?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2635244369","pubTimestamp":1778538368,"columns":[],"sourceInfo":{"source_id":"edge_highlight","name":"Edge"},"weMediaInfo":null,"summary":"Bayer AG posted better-than-expected profit in the first quarter, underpinned by a robust performance in its crop science unit, including a boost from soybean seeds and traits. Shares gained.","collect":0,"end_time":0,"defaultTopTitle":"theedgesingapore.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"SOYB":"Teucrium Soybean Fund"},"translate_title":"拜耳作物科学盈利最高预期，大豆上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SOYB":1.5},"content_text":"Bayer AG posted better-than-expected profit in the first quarter, underpinned by a robust performance in its crop science unit, including a boost from soybean seeds and traits. Shares gained.(May 12): Bayer AG posted better-than-expected profit in the first quarter, underpinned by a robust performance in its crop science unit, including a boost from soybean seeds and traits. Shares gained.\nAdjusted first-quarter earnings rose to €4.45 billion before interest, taxes, depreciation and amortisation, Bayer said Tuesday. That exceeded the €3.9 billion consensus forecast in a Bloomberg survey of analysts.\nThe company confirmed its full-year outlook on a currency-adjusted basis, saying the conflict in the Middle East doesn’t have any material impact on guidance as things stand. At the same time, it said it’s remaining vigilant in case of higher prices for energy, raw materials and logistics and will implement “appropriate countermeasures” if needed.\n“Operationally, the turnaround has taken hold and the period of repeated disappointments and profit warnings appears to be over,” Markus Manns, portfolio manager at Bayer shareholder Union Investment, said by email.\nThe shares rose as much as 5% in early trading in Frankfurt. They’re up by more than half over the past 12 months due to improvements in Bayer’s drug pipeline and investor optimism it can successfully manage its legal problems in the US.\nThe German conglomerate is navigating a critical phase in efforts to contain mass litigation tied to the Roundup weedkiller — a saga that has haunted the Leverkusen, Germany-based company since its 2018 acquisition of Roundup creator Monsanto and has already cost more than US$10 billion.\nSince taking over in mid-2023, CEO Bill Anderson has been grappling with the Roundup fallout while also trying to improve performance by trimming management layers and eliminating thousands of jobs.\nGrowth in Bayer’s crop-science business in the first quarter was mainly driven by the soybean seed and traits business, where sales doubled thanks to a €448 million licensing payment tied to a seed-technology dispute. Prices also recovered thanks to the re-approval of the soy crop herbicide dicamba.\nThe crop-protection business, however, remained under pressure with declining sales. Bayer has tried to improve the crop-science unit’s margins as part of its efficiency programme that also includes exiting less-profitable products.\nIn its pharmaceutical division, Bayer continued to suffer from generic competition to Xarelto, with sales of the blockbuster blood thinner slumping by 40% in the quarter, as well as the eye medicine Eylea. The company is counting on growth from cancer drug Nubeqa and kidney therapy Kerendia, as well as new launches, to return the unit to growth by 2027.\nPerformance at the smallest division, consumer health, was held back by continuing weakness in the US and relatively weaker demand for drugs for the cold season.\nOverall, the results are “strong” and show better-than-expected profitability in both the pharmaceutical and crop-science businesses, JPMorgan analysts including Richard Vosser said in a note, highlighting that the company expects a weaker currency-related headwind.\nBeyond operating performance, Bayer and its investors are closely watching a US Supreme Court decision expected by the end of June that could undercut the failure-to-warn legal argument underpinning most Roundup claims.\nIn addition to a favourable ruling, Bayer must also secure broad participation in its US$7.25 billion settlement. Claimants have until June 4 to opt in or out.\nUploaded by Arion Yeow","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635244369","isCrawlerRequest":true}